ANTIBODIES AND REAGENTS MARKET REPORT OVERVIEW
-
Request Free Sample PDF to learn more about this report
The global antibodies and reagents market size is estimated to be USD 268.7 million in 2022 and the market is projected to touch USD 374.7 million by 2028, with a growing CAGR of 5.7% during the forecast period. The global COVID-19 pandemic has been unprecedented and staggering, with antibodies and reagents experiencing higher-than-anticipated demand across all regions compared to pre-pandemic levels.
Antibodies can be classified as either monoclonal or polyclonal. It is also known as immunoglobulin (Ig). It helps to recognize a specific molecule of the pathogen, called an antigen. Y-shaped protein is extensively used to neutralize and identify foreign objects in the body, such as pathogenic viruses and bacteria. Antibodies are formed by plasma T or B cells in the human body.
High demand for high-quality antibodies for research reproducibility. Rise in R&D activities in the healthcare and life sciences industry is expected to drive market growth. Increase in economic volatility and evolving technology advancement. Further, growing focus on new analytical technologies among researchers and students. Market players are collaborating with academic institutions to create awareness. These factors are expected to fuel market growth in the upcoming years. However, lack of reproducible results and quality concerns are expected to cause a crisis in the market progress. Also, pricing pressure and high competition among prominent market players are estimated to hinder antibodies and reagents market growth.
COVID-19 Impact: Growing Research Activities and Demand for Vaccines to Fuel Market Growth
Research activities were boosted during the pandemic period. Increase in research activities fueled both funding and availability of the antibodies. Growing demand for vaccines during the pandemic to fight against coronavirus boost product adoption. An outbreak of COVID-19 pandemic increases the profit rate of companies. High demand for faster testing and research to expand market progress. Increase in collaboration among institutes and key players to discover COVID-19 vaccines developed market growth.
LATEST TRENDS
"Increase in Academic and Industry Collaboration to Foster Market Growth"
Growing number of collaboration between academics and institutions is anticipated to fuel market growth. The primary purpose of the collaboration is to transfer knowledge and technology from industries and academics and vice versa. Further, the partnership will help to create awareness. Growth in economic volatility and evolving technological advancement are expected to fuel market growth. Rapid adoption of research antibodies and regents in the research industry. And growing need for drug discovery and development. These factors are predicted to fuel market growth. Increasing number of chronic diseases globally and high demand to improve the healthcare sector. Antibodies have a strong affinity and long-term memory against unique pathogens. They are used in various applications such as research studies and others. The factors are anticipated to accelerate antibodies and reagents market growth in the upcoming years.
ANTIBODIES AND REAGENTS MARKET SEGMENTATION
-
Request Free Sample PDF to learn more about this report
- By Type
Based on type, the market is divided into ELISA, flow cytometry, immunofluorescence, western blotting, and others.
Flow cytometry is expected to be the leading part of the segmentation type.
-
By Application
Based on the application, the market is divided into pharmaceutical & biotechnological companies, academic & research institutes, contract research organizations, and others.
Academic & research institutes are expected to be the leading part of application segmentation.
DRIVING FACTORS
"Protein Therapeutics and Personalized Medicine to Incite Market Growth "
Increasing prominence of personalized medicine in the healthcare sector is expected to fuel market growth. Personalized medicine act as a core area of research and clinical practices. Increase in R&D investments by biopharmaceutical companies in personalized medicine. High demand for personalized and protein therapeutics, along with public and private sector spending on it, is likely to aid industry growth. Growth in pharmaceutical sectors and increased accessibility to introduce innovative products. Rising need for drug discovery and development is anticipated to surge market growth. A high focus on antibodies and cell-based research are expected to drive market progress. Focus on identifying and researching various modifications, genetic variants, and modifications and their relevance to other diseases are expected to witness lucrative opportunities in the market growth. In addition, immediate need for quantitative methods to identify or examine protein and post-translational modifications for patients. These factors are anticipated to surge antibodies and reagents market growth in the forthcoming years.
"Growth in Research Industry and High Demand for Antibodies to Stimulate Market Growth"
Increase demand for high-quality antibodies in research industry is estimated to propel market growth. Government support and regulation to develop a new product. Also, rise in stem cell and neurobiology research projects. Such factors are anticipated to accelerate market growth. High demand for research antibodies and reagent technologies is predicted to fuel market growth in the upcoming years. Increasing need to improve the healthcare sector and increasing prevalence of chronic diseases is anticipated to fuel market growth in the forthcoming years. High demand for high-quality vaccines in research and healthcare sector is expected to surge antibodies and reagents market growth.
RESTRAINING FACTORS
"Lack of Reproducible Results and Quality Concerns to Hamper Market Growth"
Lack of reproducible results and quality concerns are expected to create a crisis in the market progress. Also, pricing pressure and high competition among prominent market players are estimated to hinder market growth in the forthcoming years.
ANTIBODIES AND REAGENTS MARKET REGIONAL INSIGHTS
-
Request Free Sample PDF to learn more about this report
"Investment by Key Players in North America to Drive Market Share"
North America is estimated to account most prominent antibodies and reagents market share due to high investment by key players. Increasing need to develop structure-based drug designs and expand research field for proteomics and genomics. Rise in research and development activities in healthcare sector along with collaboration between academic and institution. These factors are responsible for accelerating market growth. Growing focus on new analytical technologies among researchers and students. High demand for high-quality antibodies for research reproducibility is expected to fuel market growth in the upcoming years.
KEY INDUSTRY PLAYERS
"Leading Players Adopt New Strategies to Stay Competitive"
The report covers information about the list of market players and their latest development in the industry. The information includes mergers, partnerships, acquisitions, technological developments, and production lines. Other aspects examined for this market include complete research on companies producing and introducing the latest products, regions they conduct their operations in, automation, technology adoption, generating the most revenue, and making a difference with their products.
List of Market Players Profiled
- Thermo Fisher Scientific (U.S.)
- Merck Millipore (Germany)
- Danaher (U.S.)
- Siemens Healthcare (Germany)
- Bio-Rad Laboratories (U.S.)
- Roche (Switzerland)
- Sysmex (Japan)
- PerkinElmer (U.S.)
- Abcam (U.K.)
- BD (U.S.)
- Agilent Technologies (U.S.)
REPORT COVERAGE
This research profiles a report with general studies that explain the firms that exist in the market affecting the forecasting period. With detailed studies done, it also offers a comprehensive analysis by examining the factors like segmentation, opportunities, industrial developments, trends, growth, size, share, restraints, and others. This analysis is subject to alteration if the key players and probable analysis of market dynamics change.
| REPORT COVERAGE | DETAILS |
|---|---|
Market Size Value In |
US$ 268.7 Million in 2022 |
Market Size Value By |
US$ 374.7 Million by 2028 |
Growth Rate |
CAGR of 5.7% from 2022 to 2028 |
Forecast Period |
2022-2028 |
Base Year |
2022 |
Historical Data Available |
Yes |
Segments Covered |
Types & Application |
Regional Scope |
Global |
Frequently Asked Questions
-
What value is the market expected to touch by 2028?
The global antibodies and reagents market is expected to reach USD 374.7 million by 2028.
-
What CAGR is the market expected to exhibit by 2028?
The market is expected to exhibit a CAGR of 5.7% by 2028.
-
Which are the driving factors of the market?
Drivers of this market are protein therapeutics and personalized medicine and growth in research industry and high demand for antibodies.
-
Which are the top companies operating in the market?
Thermo Fisher Scientific, Merck Millipore, Danaher, Siemens Healthcare, Bio-Rad Laboratories, Roche, Sysmex, PerkinElmer, Abcam, BD, and Agilent Technologies.
